IVF Success Rate in Nepal: What Factors Affect Your Chances of Pregnancy?

Understand IVF success rate in Nepal, the factors that influence pregnancy and live birth, and the questions to ask before choosing treatment.

The IVF success rate in Nepal cannot be represented accurately by one percentage that applies to every patient. A person’s chances are influenced by age, egg and sperm health, infertility diagnosis, embryo development, uterine factors, previous reproductive history and the treatment approach used.

The way a clinic calculates success is equally important. A pregnancy rate per embryo transfer is not the same as a live birth rate per cycle started. Therefore, anyone considering IVF in Nepal should ask what outcome is being measured and whether the clinic’s data apply to patients with a similar age, diagnosis and treatment plan.

This article explains the major IVF success factors, how to interpret clinic statistics and which questions to discuss with a fertility specialist.

What does “IVF success rate” actually mean?

An IVF success rate describes the proportion of treatments that reach a specified outcome. However, “success” may refer to several different stages—from a positive pregnancy test to the birth of a baby.

The most meaningful outcome for many patients is the live birth rate, but clinics may also report fertilisation, implantation or clinical pregnancy rates. These figures answer different questions and should not be compared as though they are identical.

Common IVF outcome measurements

The denominator matters as much as the outcome. A clinic may calculate results:

• per cycle started;
• per egg retrieval;
• per embryo transfer;
• per fresh transfer;
• per frozen transfer;
• or cumulatively across several transfers.

A per-transfer figure excludes cycles that did not produce an embryo suitable for transfer. It may therefore appear higher than a per-cycle-started figure.

The CDC advises that ART outcomes vary according to patient age, infertility diagnosis, previous pregnancy and the procedures used. It also cautions that population averages may not represent an individual patient’s chance.

Is there one reliable IVF success rate for Nepal?

No single publicly established percentage can accurately describe every IVF treatment performed in Nepal.

A national figure would require consistent reporting from clinics using the same definitions, outcomes, patient categories and time periods. Without those conditions, percentages from different clinics may not be directly comparable.

International datasets can show broader patterns, but they should not be presented as Nepal-specific outcomes. For example, the UK fertility regulator reported that in 2023 the average fresh-transfer birth rate per embryo transferred was 35% for patients aged 18–34 using their own eggs and 5% for patients aged 43–44. Those figures illustrate the influence of age, but they describe UK treatment data—not predicted outcomes for an individual in Nepal.

When evaluating a claim about IVF success in Nepal, ask:

1. Does the figure refer to pregnancy or live birth?
2. Is it measured per cycle, retrieval or embryo transfer?
3. Which age groups are included?
4. Does it include own-egg, donor-egg, fresh and frozen cycles together?
5. What period and number of treatments does it cover?

A trustworthy explanation should make these details easy to understand.

Which factors affect IVF success?

IVF outcome is usually shaped by several connected factors rather than one isolated test result.

1. Age and egg quality

Age is one of the strongest predictors of IVF outcome when a patient is using their own eggs.

As ovarian ageing progresses, both the number of available eggs and the proportion of eggs capable of developing into chromosomally suitable embryos generally decline. This can affect fertilisation, embryo development, implantation, miscarriage risk and live birth.

Age should not be interpreted in isolation. Two people of the same age may have different ovarian responses, medical histories and treatment outcomes. However, age remains essential when a clinic presents segmented success information. HFEA data demonstrate substantial differences in live-birth rates across age groups, while CDC reporting also identifies age as a major patient characteristic affecting ART outcomes.

2. Ovarian reserve and ovarian response

Ovarian reserve refers to the remaining quantity of eggs, although it does not directly measure the genetic quality of every egg.

A fertility assessment may include:

• anti-Müllerian hormone testing;
• antral follicle count by ultrasound;
• menstrual and ovulation history;
• and other hormone tests selected by the clinician.

These results help the specialist estimate how the ovaries may respond to stimulation and develop an appropriate treatment plan. A lower ovarian reserve may reduce the number of eggs retrieved, but it does not by itself prove that pregnancy is impossible.

New Life IVF’s fertility-screening service describes hormone profiling, ovarian-reserve testing, ultrasound, ovulation assessment and semen analysis as parts of reproductive evaluation.

3. The underlying cause of infertility

Different diagnoses create different challenges during IVF.

IVF may be considered for conditions such as:

• blocked or damaged fallopian tubes;
• endometriosis;
• ovulation-related disorders;
• reduced ovarian reserve;
• male-factor infertility;
• genetic concerns;
• or unexplained infertility.

WHO defines infertility as a disease of the male or female reproductive system involving failure to achieve pregnancy after 12 months or more of regular unprotected intercourse. Causes may involve either partner or remain unexplained after evaluation.

The diagnosis can affect the stimulation plan, fertilisation method, likelihood of obtaining usable embryos and the additional treatment required.

4. Sperm health and male-factor infertility

IVF success is not determined by female factors alone.

Semen assessment commonly examines:

• sperm concentration;
• movement or motility;
• shape or morphology;
• semen volume;
• and other findings when clinically indicated.

Severe sperm abnormalities may affect fertilisation and embryo development. In some cases, intracytoplasmic sperm injection may be considered. During ICSI, an embryologist injects a selected sperm directly into an egg.

However, ICSI is a treatment technique, not a guarantee of embryo development or live birth. Its appropriateness depends on the couple’s diagnosis and laboratory findings.

New Life IVF lists both IVF treatment and ICSI among its fertility services.

5. Number and maturity of retrieved eggs

Not every follicle produces an egg, not every egg is mature and not every mature egg fertilises.

The number of eggs retrieved can influence the number of opportunities available for fertilisation and embryo development. Still, more eggs do not automatically mean that a cycle will result in pregnancy. The response must be interpreted alongside egg maturity, patient safety and embryo development.

The clinical team adjusts ovarian stimulation using the patient’s age, ovarian reserve, previous response and monitoring results. Excessively aggressive stimulation is not a substitute for individualised care.

6. Fertilisation and embryo development

After retrieval, mature eggs are fertilised through conventional IVF or ICSI when indicated. Embryologists then observe how the embryos develop.

Embryo evaluation may consider:

• the pace and pattern of cell division;
• visible morphology;
• developmental stage;
• progression to the blastocyst stage;
• and clinical information relevant to selection.

Embryo grading can help a laboratory rank embryos, but it cannot predict the outcome with certainty. A visually strong embryo may not implant, while an embryo with a lower grade may still result in a healthy birth.

Laboratory conditions and accurate embryo assessment are important parts of IVF care. ESHRE guidance describes the incubation environment and embryo selection as important contributors to treatment outcomes.

7. Embryology laboratory standards

The embryology laboratory handles eggs, sperm and embryos during highly sensitive stages.

Relevant laboratory considerations include:

• stable temperature and pH;
• air quality;
• incubator performance;
• equipment maintenance;
• identification and witnessing systems;
• infection-control processes;
• embryologist training;
• cryopreservation procedures;
• and quality monitoring.

ESHRE laboratory guidance includes recommendations relating to embryo handling, laboratory conditions, identity checks and maintaining appropriate conditions during embryo transport and transfer.

A clinic should be able to explain its laboratory processes clearly without relying only on terms such as “advanced” or “world-class.”

8. Endometrial and uterine factors

A developing embryo must implant in the lining of the uterus, called the endometrium.

The clinical team may evaluate:

• endometrial development;
• uterine shape;
• fibroids or polyps;
• adhesions;
• inflammation or other abnormalities;
• and the timing of progesterone and embryo transfer.

A single measurement, including endometrial thickness, should not be treated as a complete predictor. The specialist interprets uterine findings together with embryo, hormonal and medical factors.

9. Embryo-transfer planning

Embryo transfer involves placing an embryo into the uterus at an appropriate time.

The plan may include decisions about:

• fresh or frozen transfer;
• developmental stage at transfer;
• number of embryos transferred;
• catheter technique;
• and cycle preparation.

Transferring multiple embryos can increase the risk of twins or higher-order multiple pregnancy. It should not be viewed simply as a way to “double” success. ASRM notes that higher use of elective single-embryo transfer in appropriate younger patients can reduce multiple gestations without significantly lowering clinic-level live-birth rates.

ESHRE similarly recommends individualised decision-making concerning the number of embryos transferred.

10. Fresh versus frozen embryo transfer

A fresh embryo transfer occurs during the egg-retrieval treatment cycle. A frozen embryo transfer takes place in a later prepared cycle after an embryo has been cryopreserved.

Neither approach is automatically best for every patient. The decision may depend on:

• hormonal response;
• embryo availability;
• risk of ovarian hyperstimulation;
• endometrial conditions;
• need for genetic testing;
• and the clinician’s treatment strategy.

New Life IVF provides a separate frozen-embryo-transfer service as part of its broader fertility-treatment options.

11. Previous pregnancy and treatment history

Previous pregnancies, miscarriages, IVF attempts, ovarian responses and embryo development can help the specialist understand the current prognosis.

An unsuccessful cycle does not always mean that the same result will occur again. It may provide useful information about:

• medication response;
• egg maturity;
• fertilisation;
• embryo progression;
• transfer conditions;
• or the need for further investigation.

Any proposed change should be linked to a clinical finding rather than based solely on the assumption that every add-on improves success.

12. General and preconception health

Smoking, unmanaged medical conditions, certain medicines and other health factors may affect fertility or pregnancy safety.

Before IVF, patients should provide a complete medical history and discuss:

• smoking or tobacco exposure;
• alcohol use;
• current medicines and supplements;
• diabetes, thyroid or other medical conditions;
• vaccinations where relevant;
• sleep and mental well-being;
• and nutritional health.

Lifestyle changes should support overall reproductive and pregnancy health, but they cannot reverse every age-related, anatomical, genetic or severe fertility factor.

Patients should avoid unverified fertility supplements or restrictive diets without professional advice. A personalised recommendation should come from the treating clinician.

Contextual CTA: A clinic-wide percentage cannot replace an individual evaluation. Couples considering IVF can begin with comprehensive fertility screening to understand the factors that may influence their treatment plan.

How should you interpret an IVF success-rate claim?

Use the following framework before relying on a percentage.

The practical lesson is simple: the best-looking percentage is not necessarily the most meaningful percentage.

Can you improve your chances of IVF success?

Some factors can be evaluated or managed, while others—particularly reproductive ageing—cannot be fully controlled.

Before treatment

1. Complete an assessment of both partners.
2. Share all previous fertility records and treatment reports.
3. Ask how age and diagnosis affect the proposed plan.
4. Review medical conditions and current medicines.
5. Stop smoking and discuss alcohol use with the clinician.
6. Follow evidence-based preconception advice.
7. Ask which additional tests are genuinely indicated.

During treatment

• Take medicines exactly as prescribed.
• Attend monitoring appointments.
• Report severe or unexpected symptoms promptly.
• Follow the clinic’s instructions before egg retrieval and transfer.
• Clarify whom to contact outside normal hours.
• Ask why any optional procedure or treatment add-on is being recommended.

After embryo transfer

Patients should follow the clinic’s medical instructions and continue prescribed medicines unless advised otherwise. Strict bed rest, unverified remedies and self-directed medication changes should not be assumed to improve implantation.

How do you choose an IVF clinic in Nepal?

Choose a clinic based on transparent reporting, clinical expertise, laboratory quality, patient safety and communication—not one headline success claim.

Questions to ask an IVF clinic

About success data

• Do you report clinical pregnancy or live birth?
• Is the rate per cycle started or per embryo transfer?
• Can you provide age-specific outcomes?
• Are own-egg and donor-egg results separated?
• Are fresh and frozen transfers reported separately?
• What time period does the data cover?
• How many cycles are included?
• Are cancelled cycles counted?

About clinical care

• Who will lead the fertility assessment?
• Will both partners be evaluated?
• How is the stimulation protocol selected?
• When is ICSI recommended?
• How do you decide whether to use fresh or frozen transfer?
• What is the policy on the number of embryos transferred?
• How are complications identified and managed?

About the laboratory

• Who supervises the embryology laboratory?
• How are eggs, sperm and embryos identified?
• How are temperature, air quality and incubators monitored?
• What are the cryopreservation and storage processes?
• How are fertilisation and embryo-development updates communicated?

About costs and consent

• Which services are included in the quoted price?
• Which medicines, tests or procedures may cost extra?
• Are optional add-ons supported by evidence for this diagnosis?
• What happens financially if the cycle is cancelled?
• How are embryos stored, used or disposed of with consent?

New Life IVF identifies Dr. Salma Banu as a gynecologist and IVF specialist and provides appointment details through her verified doctor profile. The clinic’s About page also outlines its stated approach to personalised and evidence-based fertility care.

When should you consult an IVF specialist?

A fertility evaluation is generally appropriate after 12 months of regular unprotected intercourse without pregnancy. Earlier evaluation may be appropriate when age, irregular or absent periods, known tubal disease, endometriosis, recurrent pregnancy loss, previous cancer treatment, significant male-factor concerns or another known reproductive condition is present.

WHO uses 12 months as the general definition of infertility, but the correct timing for an individual assessment depends on age and medical history.

Seeking an assessment does not mean that IVF will automatically be recommended. Depending on the findings, options may include timed intercourse, ovulation treatment, surgery, IUI, IVF, ICSI, fertility preservation or another appropriate pathway.

Key takeaways

• There is no single IVF percentage that applies to every patient in Nepal.
• Age is an important factor when using one’s own eggs, but diagnosis, sperm health, embryo development and uterine factors also matter.
• Pregnancy rate and live birth rate are not interchangeable.
• Per-transfer rates can appear higher than per-cycle-started rates.
• Clinic percentages should be segmented by age, treatment type and outcome.
• A success rate is a population statistic—not a promise for one patient.
• Both partners should be evaluated.
• Transparent counselling and an individual treatment plan are more useful than an unexplained headline percentage.

Frequently Asked Questions

What does IVF success rate actually mean?

IVF success rate is the percentage of treatments reaching a defined outcome, such as clinical pregnancy or live birth. The figure is incomplete unless the clinic also explains whether it is calculated per cycle started, egg retrieval or embryo transfer and which patient and treatment groups are included.

What is the IVF success rate in Nepal?

There is no single publicly established figure that accurately represents all IVF treatment in Nepal. Clinic results may differ because of patient age, diagnosis, treatment type, laboratory practices and reporting method. Ask for recent, age-specific live-birth or clinical-pregnancy data with a clearly defined denominator.

Is the pregnancy rate the same as the live birth rate?

No. A pregnancy rate may reflect a positive test or an ultrasound-confirmed pregnancy, while a live birth rate measures treatment resulting in a live-born baby. Because pregnancy loss can occur, the live birth rate is generally lower and often more meaningful to patients.

Does age affect IVF success?

Yes, particularly when a patient uses their own eggs. As age increases, the number of eggs and the proportion capable of producing chromosomally suitable embryos generally decline. However, an individual prognosis also depends on ovarian reserve, sperm health, diagnosis, embryo development and medical history.

Is IVF always successful on the first attempt?

No. Some patients conceive after one cycle, while others require more than one retrieval or embryo transfer, and some do not achieve a live birth with IVF. A specialist should explain both the chance per attempt and, where appropriate, the cumulative chance across available embryos or multiple cycles.

Does a normal AMH result guarantee IVF success?

No. AMH helps estimate ovarian reserve and likely response to stimulation, but it does not directly confirm egg quality, embryo viability, implantation or live birth. Age, sperm factors, fertilisation, embryo development and uterine conditions must also be considered.

Does a low AMH level mean IVF cannot work?

Not necessarily. A low AMH result may indicate a lower expected ovarian response and potentially fewer retrieved eggs. It does not prove that no usable egg or embryo can be obtained. The result should be interpreted with age, ultrasound findings, history and previous treatment response.

Does sperm quality affect IVF outcomes?

Yes. Sperm concentration, movement, morphology and other factors can influence fertilisation and embryo development. ICSI may be recommended in selected male-factor cases, but it does not guarantee pregnancy. Both partners should therefore be assessed before a treatment plan is finalised.

Does embryo grade guarantee implantation?

No. Embryo grading helps embryologists assess visible development and rank embryos, but it cannot predict implantation or live birth with certainty. Embryo genetics, uterine factors, transfer conditions and other biological variables can influence the outcome.

Is transferring two embryos better than transferring one?

Not automatically. Two embryos may increase the possibility of multiple pregnancy, which carries additional risks for the pregnant patient and babies. The safest number depends on age, embryo stage and quality, treatment history and professional guidelines. The decision should be individualised.

Can stress cause IVF to fail?

IVF outcomes cannot usually be attributed to one stressful day or emotion. Fertility treatment can be emotionally demanding, and appropriate support may improve coping and well-being. Patients should not be blamed for an unsuccessful cycle because they felt anxious or stressed.

Can diet or supplements improve IVF success?

A balanced diet and appropriate preconception care support general health, but no food or supplement guarantees implantation or live birth. Some supplements may interact with treatment or be unnecessary. Patients should discuss vitamins, herbal products and medicines with their fertility clinician.

How should I compare IVF clinics in Nepal?

Compare clearly defined age-specific outcomes, clinical qualifications, laboratory processes, embryo-transfer policies, safety procedures, counselling, costs and consent practices. Do not rely only on the largest advertised percentage. Ask whether the rate represents pregnancy or live birth and which cycles are included.

When should I see an IVF specialist?

Consider a fertility assessment after 12 months without pregnancy, or sooner when age or a known reproductive condition may make delay important. Irregular periods, tubal disease, endometriosis, recurrent loss, previous gonadotoxic treatment or significant semen abnormalities may justify earlier evaluation.